- Filed
- Apr 16, 2024 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2023 · May 15, 2023 | 8.31M sh |
| Shares Diluted | Q2 2023 · Mar 31, 2023 | 8.31M sh |
| Shares Diluted | Q2 2023 · Mar 31, 2023 | 8.28M sh |
| Shares Diluted | Q2 2023 · Mar 31, 2022 | 6.96M sh |
| Shares Diluted | Q2 2023 · Mar 31, 2022 | 6.94M sh |
| Operating Cash Flow | Q2 2023 · Mar 31, 2023 | −$33.81K |
| Operating Cash Flow | Q2 2023 · Mar 31, 2022 | −$201.94K |
| Cash And Equivalents | Q2 2023 · Mar 31, 2023 | $2.57K |
| Cash And Equivalents | Q2 2023 · Sep 30, 2022 | $36.38K |
| Stockholders Equity | Q2 2023 · Mar 31, 2023 | −$232.74K |
| Stockholders Equity | Q2 2023 · Dec 31, 2022 | $608.01K |
| Stockholders Equity restated | Q2 2023 · Sep 30, 2022 | $819.54K |
| Stockholders Equity | Q2 2023 · Mar 31, 2022 | −$798.13K |
| Stockholders Equity | Q2 2023 · Dec 31, 2021 | −$800.43K |
| Stockholders Equity restated | Q2 2023 · Sep 30, 2021 | −$599.25K |
| Current Liabilities | Q2 2023 · Mar 31, 2023 | $1.6M |
| Current Liabilities | Q2 2023 · Sep 30, 2022 | $1.3M |
| Total Liabilities | Q2 2023 · Mar 31, 2023 | $1.61M |
| Total Liabilities | Q2 2023 · Sep 30, 2022 | $1.31M |
| Current Assets | Q2 2023 · Mar 31, 2023 | $1.38M |
| Current Assets restated | Q2 2023 · Sep 30, 2022 | $2.13M |
| Total Assets | Q2 2023 · Mar 31, 2023 | $1.38M |
| Total Assets restated | Q2 2023 · Sep 30, 2022 | $2.13M |
| Eps Diluted | Q2 2023 · Mar 31, 2023 | −$0.10 |
| Eps Diluted | Q2 2023 · Mar 31, 2023 | −$0.21 |
| Eps Diluted restated | Q2 2023 · Mar 31, 2022 | −$0.03 |
| Eps Diluted | Q2 2023 · Mar 31, 2022 | −$0.07 |
| Eps Basic | Q2 2023 · Mar 31, 2023 | −$0.10 |
| Eps Basic | Q2 2023 · Mar 31, 2023 | −$0.21 |
| Eps Basic restated | Q2 2023 · Mar 31, 2022 | −$0.03 |
| Eps Basic | Q2 2023 · Mar 31, 2022 | −$0.07 |
| Sga Expense | Q2 2023 · Mar 31, 2023 | $1.13K |
| Sga Expense | Q2 2023 · Mar 31, 2023 | $5.16K |
| Sga Expense restated | Q2 2023 · Mar 31, 2022 | $2.6K |
| Sga Expense restated | Q2 2023 · Mar 31, 2022 | $6.3K |
| Net Income | Q2 2023 · Mar 31, 2023 | −$840.75K |
| Net Income restated | Q2 2023 · Mar 31, 2023 | −$1.73M |
| Net Income | Q2 2023 · Mar 31, 2023 | −$1.73M |
| Net Income | Q2 2023 · Mar 31, 2022 | −$203.96K |
| Net Income restated | Q2 2023 · Mar 31, 2022 | −$498.13K |
| Net Income | Q2 2023 · Mar 31, 2022 | −$498.13K |
| Operating Income | Q2 2023 · Mar 31, 2023 | −$707.25K |
| Operating Income restated | Q2 2023 · Mar 31, 2023 | −$1.45M |
| Operating Income | Q2 2023 · Mar 31, 2023 | −$1.45M |
| Operating Income | Q2 2023 · Mar 31, 2022 | −$86.15K |
| Operating Income restated | Q2 2023 · Mar 31, 2022 | −$261.69K |
| Operating Income | Q2 2023 · Mar 31, 2022 | −$261.69K |
| Revenue | Q2 2023 · Mar 31, 2023 | $33.37K |
| Revenue restated | Q2 2023 · Mar 31, 2023 | $53.39K |
| Revenue | Q2 2023 · Mar 31, 2023 | $53.39K |
| Revenue | Q2 2023 · Mar 31, 2022 | $29.64K |
| Revenue restated | Q2 2023 · Mar 31, 2022 | $51.91K |
| Revenue | Q2 2023 · Mar 31, 2022 | $53.39K |